Complex role of heme oxygenase-1 in angiogenesis

Antioxidants and Redox Signaling

Volumn 6, Issue 5, 2004, Pages 858-866

  Dulak, Józef ^a   Łoboda, Agnieszka ^a   Zagórska, Anna ^a   Józkowicz, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; CARBON MONOXIDE; HEME OXYGENASE 1; IRON; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VIRUS VECTOR;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; BLOOD FLOW; CAPILLARY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME MECHANISM; GENE EXPRESSION; HUMAN; INFLAMMATION; ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; STRESS; VASCULAR DISEASE;

ANIMALS; CAPILLARIES; CELL LINE; ENDOTHELIAL CELLS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; IRON; MEMBRANE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4544350138     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2004.6.858     Document Type: Review

References (87)

1. Abraham NG, Scapagnini G, and Kappas A. Human heme oxygenase: cell cycle-dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells. J Cell Biochem 90: 1098-1111, 2003.
2. Agarwal A, Shiraishi F, Visner GA, and Nick HS. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells. J Am Soc Nephrol 9: 1990-1997, 1998.
3. Baranano DE, Wolosker H, Bae BI, Barrow RK, Snyder SH, and Ferri, CD. A mammalian iron ATPase induced by iron. J Biol Chem 275: 15166-15173, 2000.
4. Baranano DE, Rao M, Ferris CD, and Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 99: 16093-16098, 2002.
5. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Scares MP. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
6. Bruick RK and McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340, 2001.
7. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard DO, and Mason JC. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103: 761-766, 2003.
8. Carmeliet P. Angiogenesis in health and disease. Nat Med 9: 653-660, 2003.
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
10. Dennery PA, Visner G, Weng YH, Nguyen X, Lu F, Zander D, and Yang G. Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron. Free Radic Biol Med 34: 124-133, 2003.
11. Deramaudt BM, Braunstein S, Remy P, and Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121-127, 1998.
12. Dulak J and Jozkowicz A. Carbon monoxide - a "new" gaseous modulator of gene expression. Acta Biochim Pol 50: 31-47, 2003.
13. Dulak J and Jozkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 5: 123-132, 2003.
14. Dulak J, Jozkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, Florek I, Wojtowicz A, Szuba A, and Cooke JP. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 659-666, 2000.
15. Dulak J, Jozkowicz A, Dichtl W, Alber H, Schwarzacher SP, Pachinger O, Weidinger F, and Dulakk J. Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation. Atherosclerosis 159: 325-332, 2001.
16. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, and Motterlini R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240, 2002.
17. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, and Ratcliffe PJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54, 2001.
18. Eyssen-Hernandez R, Ladoux A, and Frelin C. Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Lett 382: 229-233, 1996.
19. Fernandez M and Bonkovsky HL. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br J Pharmacol 139: 634-640, 2003.
20. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 29: 10-14, 2002.
21. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, and Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
22. Ferrara N, Gerber HP, and LeCouter J. The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
23. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Dore S, Poss KD, and Snyder SH. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1: 152-157, 1999.
24. Frank S, Madlener M, Pfeilschifter J, and Werner S. Induction of inducible nitric oxide synthase and its corresponding tetrahydrobiopterin- cofactor-synthesizing enzyme GTP-cyclohydrolase 1 during cutaneous wound repair. J Invest Dermatol 111: 1058-1064, 1998.
25. Frank S, Stallmeyer B, Kampfer H, Kolb N, and Pfeilschifter J. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 13: 2002-2014, 1999.
26. Frank S, Stallmeyer B, Kampfer H, Schaffner C, and Pfeilschifter J. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem J 338 (Pt 2): 367-374, 1999.
27. Frankel D, Mehindate K, and Schipper HM. Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J Cell Physiol 185: 80-86, 2000.
28. Grzenkowicz-Wydra J, Cisowski J, Nakonieczna J, Zarêbski A, Udilova N, Nohl H, Józkowicz A, Podhajska A, and Dulak J. Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor. Mol Cell Biochem 2004 (in press).
29. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, and Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5: 1135-1142, 1999.
30. Hill-Kapturczak N, Chang SH, and Agarwal A. Heme oxygenase and the kidney. DNA Cell Biol 21: 307-321, 2002.
31. Hill-Kapturczak N, Voakes C, Garcia J, Visner G, Nick HS, and Agarwal A. A cis-acting region regulates oxidized lipid-mediated induction of the human heme oxygenase-1 gene in endothelial cells. Arterioscler Thromb Vase Biol 23: 1416-1422, 2003.
32. Inoue M, Itoh H, Tanaka T, Chun TH, Doi K, Fukunaga Y, Sawada N, Yamshita J, Masatsugu K, Saito T, Sakaguchi S, Sone M, Yamahara Ki, Yurugi T, and Nakao K. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vase Biol 21: 560-566, 2001.
33. Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, Ikehara K, Matsuse T, and Ishigatsubo Y. Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther 12: 967-979, 2001.
34. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim AV, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, and Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by deregulated prolyl hydroxylation. Science 292: 468-472, 2001.
35. Jozkowicz A, Dulak J, Piatkowska E, Placha W, and Dembinska-Kiec A. Ligands of peroxisome proliferator-activated receptor-gamma increase the generation of vascular endothelial growth factor in vascular smooth muscle cells and in macrophages. Acta Biochim Pol 47: 1147-1157, 2000.
36. Jozkowicz A, Cooke JRevara I, Huk I, Funovics P, Pachinger O, Weidinger F, and Dulak J. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 51: 773-783, 2001.
37. 2 on VEGF synthesis depends on the induction of heme oxygenase-1. Antioxid Redox Signal 4: 577-585, 2002.
38. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, and Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003.
39. Ke B, Buelow R, Shen XD, Melinek J, Amersi F, Gao F, Ritter T, Volk HD, Busuttil RW, and Kupiec-Weglinski JW. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 13: 1189-1199, 2002.
40. Kimura H and Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 50: 49-59, 2003.
41. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, and Esumi H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95: 189-197, 2000.
42. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, and Esumi H. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276: 2292-2298, 2001.
43. Kimura H, Ogura T, Kurashima Y, Weisz A, and Esumi H. Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem Biophys Res Commun 296: 976-982, 2002.
44. Kreiser D, Nguyen X, Wong R, Seidman D, Stevenson D, Quan S, Abraham N, and Dennery PA. Heme oxygenase-1 modulates fetal growth in the rat. Lab Invest 82: 687-692, 2002.
45. Lee TS and Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240-246, 2002.
46. Leibovich SJ, Chen JF, Pinhal-Enfield G, Belem PC, Elson G, Rosania A, Ramanathan M, Montesinos C, Jacobson M, Schwarzschild MA, Fink JS, and Cronstein B. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am J Pathol 160: 2231-2244, 2002.
47. Liu Y, Christou H, Morita T, Laughner E, Semenza GL, and Kourembanas S. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J Biol Chem 273: 15257-15262, 1998.
48. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
49. Maines MD. Bile pigments: newcomers to the cell signaling arena. Toxicol Sci 71: 9-10, 2003.
50. Marti HH and Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A 95: 15809-15814, 1998.
51. McNeill LA, Hewitson KS, Gleadle JM, Horsfall LE, Oldham NJ, Maxwell PH, Pugh CW, Ratcliffe PJ, and Schofield CJ. The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg Med Chem Lett 12: 1547-1550, 2002.
52. Metzen E, Zhou J, Jelkmann W, Fandrey J, and Brune B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell 14: 3470-3481, 2003.
53. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, and Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270: H411-H415, 1996.
54. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, and Green CJ. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 275: 13613-13620, 2000.
55. Motterlini R, Green CJ, and Foresti R. Regulation of heme oxygenase-1 by redox signals involving nitric oxide. Antioxid Redox Signal 4: 615-624, 2002.
56. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, and Green CJ. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 9: 2525-2539, 2003.
57. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
58. Nakayama M, Takahashi K, Kitamuro T, Yasumoto K, Katayose D, Shirato K, Fujii-Kuriyama Y, and Shibahara S. Repression of heme oxygenase-1 by hypoxia in vascular endothelial cells. Biochem Biophys Res Commun 271: 665-671, 2000.
59. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T, and Kuwano M. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5: 1107-1113, 1999.
60. Otterbein LE, Bach FH, Alam J, Scares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
61. Otterbein LE, Scares MP, Yamashita K, and Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455, 2003.
62. Papapetropoulos A, Garcia-Cardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
63. Piantadosi CA. Biological chemistry of carbon monoxide. Antioxid Redox Signal 4: 259-270, 2002.
64. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T, Martin S, van den Heuvel J, Weich H, Fernandez B, Golomb G, Carmeliet P, Schaper W, and Clauss M. VEGFR-1-selective VEGF homologue P1GF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 92: 378-385, 2003.
65. Poltorak Z, Cohen T, and Neufeld G. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases. Herz 25: 126-129, 2000.
66. Ponka P. Cellular iron metabolism. Kidney Int Suppl 69: S2-S11, 1999.
67. Ramanathan M, Giladi A, and Leibovich SJ. Regulation of vascular endothelial growth factor gene expression in murine macrophages by nitric oxide and hypoxia. Exp Biol Med (Maywood) 228: 697-705, 2003.
68. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13: 167-171, 2001.
69. Servos S, Zachary I, and Martin JF. VEGF modulates NO production: the basis of a cytoprotective effect? Cardiovasc Res 41: 509-510, 1999.
70. Shibahara S, Nakayama M, Kitamuro T, Udono-Fujimori R, and Takahashi K. Repression of heme oxygenase-1 expression as a defense strategy in humans. Exp Biol Med (Maywood) 228: 472-473, 2003.
71. Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J, and Frank S. The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 113: 1090-1098, 1999.
72. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
73. Sumbayev VV, Budde A, Zhou J, and Brune B. HIF-1 alpha protein as a target for 5-nitrosation. FEBS Lett 535: 106-112, 2003.
74. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, and Igarashi K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J 21: 5216-5224, 2002.
75. Suttner DM and Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 13: 1800-1809, 1999.
76. Suzuki M, Iso-o N, Takeshita S, Tsukamoto K, Mori I, Sato T, Ohno M, Nagai R, and Ishizaka N. Facilitated angiogenesis induced by heme oxygenase-1 gene transfer in a rat model of hindlimb ischemia. Biochem Biophys Res Commun 302: 138-143, 2003.
77. Templeton DM and Liu Y. Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 1619: 113-124, 2003.
78. Thom SR, Fisher D, Xu YA, Notarfrancesco K, and Ischiropoulos H. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci U S A 97: 1305-1310, 2000.
79. Tjwa M, Luttun A, Autiero M, and Carmeliet P. VEGF and P1GF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res 314: 5-14, 2003.
80. Wang GL and Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82: 3610-3615, 1993.
81. Wang LJ, Lee TS, Lee FY, Pai RC, and Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711-720, 1998.
82. Watts RN, Ponka P, and Richardson DR. Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron. Biochem J 369: 429-440, 2003.
83. Williams KJ, Telfer BA, Airley RE, Peters HP, Sheridan MR, van der Kogel AJ, Harris AL, and Stratford IJ. A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene 21: 282-290, 2002.
84. Xiong M, Elson G, Legarda D, and Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 153: 587-598, 1998.
85. Zachary I and Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49: 568-581, 2001.
86. Zhang Y, Zhao W, Zhang HJ, Domann FE, and Oberley LW. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 62: 1205-1212, 2002.
87. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, and Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997.